OX40 and OX40L Interaction in Cancer

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• OX40 (CD134) and its ligand OX40L (CD252) are key molecules expressed on activated immune cells.
• OX40L is a TNF family member, and the OX40-OX40L complex has a specific trimeric structure.
• These molecules regulate cytokine production and signaling in various immune cells, including T-cells and NK cells.

Purpose of the Study:

• To provide an updated overview of the structural features of OX40/OX40L interactions.
• To explore the role of OX40/OX40L in cancer and therapeutic strategies.

Main Methods:

• Review of structural features of OX40/OX40L.
• Analysis of recent studies on OX40 stimulation in cancer immunotherapy.

Main Results:

• OX40 stimulation is a promising strategy for cancer therapeutic immunization.
• OX40 acts as a costimulatory immune checkpoint, enhancing T-cell augmentation, survival, memory, and effector functions.
• The OX40-OX40L interaction boosts both CD4+ and CD8+ T-cell responses.

Conclusions:

• OX40-OX40L interactions are vital for CD4+ and CD8+ T-cell functions.
• OX40 signaling can suppress regulatory T-cells (Tregs), reduce Foxp3 expression, and promote memory and effector T-lymphocyte proliferation.
• Therapeutic application of OX40-OX40L interactions in tumor-bearing recipients leads to tumor elimination.